116 related articles for article (PubMed ID: 8904679)
1. Impact of triiodothyronine on the survival of high-risk patients undergoing open heart surgery.
Novitzky D; Fontanet H; Snyder M; Coblio N; Smith D; Parsonnet V
Cardiology; 1996; 87(6):509-15. PubMed ID: 8904679
[TBL] [Abstract][Full Text] [Related]
2. Inotropic effect of triiodothyronine (T3) in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: an initial experience in patients undergoing open heart surgery.
Novitzky D; Cooper DK; Swanepoel A
Eur J Cardiothorac Surg; 1989; 3(2):140-5. PubMed ID: 2627465
[TBL] [Abstract][Full Text] [Related]
3. Triiodothyronine therapy in open-heart surgery: from hope to disappointment.
Teiger E; Menasché P; Mansier P; Chevalier B; Lajeunie E; Bloch G; Piwnica A
Eur Heart J; 1993 May; 14(5):629-33. PubMed ID: 8389710
[TBL] [Abstract][Full Text] [Related]
4. Triiodothyronine administration in coronary artery bypass surgery: effect on hemodynamics.
Vavouranakis I; Sanoudos G; Manios A; Kalogeropoulou K; Sitaras K; Kokkinos C
J Cardiovasc Surg (Torino); 1994 Oct; 35(5):383-9. PubMed ID: 7995828
[TBL] [Abstract][Full Text] [Related]
5. Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting.
Ranasinghe AM; Quinn DW; Pagano D; Edwards N; Faroqui M; Graham TR; Keogh BE; Mascaro J; Riddington DW; Rooney SJ; Townend JN; Wilson IC; Bonser RS
Circulation; 2006 Jul; 114(1 Suppl):I245-50. PubMed ID: 16820580
[TBL] [Abstract][Full Text] [Related]
6. Effects of Mini-Volume Priming During Cardiopulmonary Bypass on Clinical Outcomes in Low-Bodyweight Neonates: Less Transfusion and Postoperative Extracorporeal Membrane Oxygenation Support.
Kim SY; Cho S; Choi E; Kim WH
Artif Organs; 2016 Jan; 40(1):73-9. PubMed ID: 26642833
[TBL] [Abstract][Full Text] [Related]
7. Inotropic effect of triiodothyronine following myocardial ischemia and cardiopulmonary bypass: an experimental study in pigs.
Novitzky D; Human PA; Cooper DK
Ann Thorac Surg; 1988 Jan; 45(1):50-5. PubMed ID: 3337577
[TBL] [Abstract][Full Text] [Related]
8. Continuous Metabolic Monitoring in Infant Cardiac Surgery: Toward an Individualized Cardiopulmonary Bypass Strategy.
Torre S; Biondani E; Menon T; Marchi D; Franzoi M; Ferrarini D; Tabbì R; Hoxha S; Barozzi L; Faggian G; Luciani GB
Artif Organs; 2016 Jan; 40(1):65-72. PubMed ID: 26582421
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for development of acute renal failure (ARF) requiring dialysis in patients undergoing cardiac surgery.
Suen WS; Mok CK; Chiu SW; Cheung KL; Lee WT; Cheung D; Das SR; He GW
Angiology; 1998 Oct; 49(10):789-800. PubMed ID: 9783643
[TBL] [Abstract][Full Text] [Related]
10. Triiodothyronine (T3) and cardiovascular therapeutics: a review.
Salter DR; Dyke CM; Wechsler AS
J Card Surg; 1992 Dec; 7(4):363-74. PubMed ID: 1482831
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormone and cardiac surgery.
Klemperer JD
Thyroid; 2002 Jun; 12(6):517-21. PubMed ID: 12165116
[TBL] [Abstract][Full Text] [Related]
12. Triiodothyronine in cardiac surgery.
Broderick TJ; Wechsler AS
Thyroid; 1997 Feb; 7(1):133-7. PubMed ID: 9086581
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. A randomized, double-blind, placebo- controlled trial. Duke T3 study group.
Bennett-Guerrero E; Jimenez JL; White WD; D'Amico EB; Baldwin BI; Schwinn DA
JAMA; 1996 Mar; 275(9):687-92. PubMed ID: 8594265
[TBL] [Abstract][Full Text] [Related]
14. Indonesian Study: Triiodothyronine for Infants Less than 5 Months Undergoing Cardiopulmonary Bypass.
Marwali EM; Lopolisa A; Sani AA; Rayhan M; Roebiono PS; Fakhri D; Haas NA; Slee A; Portman MA
Pediatr Cardiol; 2022 Apr; 43(4):726-734. PubMed ID: 34851445
[TBL] [Abstract][Full Text] [Related]
15. Oral triiodothyronine normalizes triiodothyronine levels after surgery for pediatric congenital heart disease*.
Marwali EM; Boom CE; Sakidjan I; Santoso A; Fakhri D; Kartini A; Kekalih A; Schwartz SM; Haas NA
Pediatr Crit Care Med; 2013 Sep; 14(7):701-8. PubMed ID: 23842591
[TBL] [Abstract][Full Text] [Related]
16. Impact of On-Bypass Red Blood Cell Transfusion on Severe Postoperative Morbidity or Mortality in Children.
Willems A; Datoussaid D; Tucci M; Sanchez Torres C; De Villé A; Fils JF; Van der Linden P
Anesth Analg; 2016 Aug; 123(2):420-9. PubMed ID: 27331784
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 6 production during cardiac surgery correlates with increasing age.
Howell KW; Cleveland JC; Meng X; Ao L; Su X; Schwartz RS; Fullerton DA
J Surg Res; 2016 Mar; 201(1):76-81. PubMed ID: 26850187
[TBL] [Abstract][Full Text] [Related]
18. Soluble human complement receptor 1 limits ischemic damage in cardiac surgery patients at high risk requiring cardiopulmonary bypass.
Lazar HL; Bokesch PM; van Lenta F; Fitzgerald C; Emmett C; Marsh HC; Ryan U;
Circulation; 2004 Sep; 110(11 Suppl 1):II274-9. PubMed ID: 15364875
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin in patients undergoing cardiopulmonary bypass in open heart surgery-first results of the Procalcitonin in Heart Surgery study (ProHearts).
Loebe M; Locziewski S; Brunkhorst FM; Harke C; Hetzer R
Intensive Care Med; 2000 Mar; 26 Suppl 2():S193-8. PubMed ID: 18470719
[TBL] [Abstract][Full Text] [Related]
20. A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial).
Bokesch PM; Szabo G; Wojdyga R; Grocott HP; Smith PK; Mazer CD; Vetticaden S; Wheeler A; Levy JH
J Thorac Cardiovasc Surg; 2012 May; 143(5):1022-9. PubMed ID: 21724197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
